For VolcanoTherapeutics Inc., the addition of Jomed NV 's IVUS business is both an addition to and diversification beyond its current play in thermography as a diagnostic tool to detect vulnerable plaque [See Deal].
As we noted in our profile of Volcano (see "Vulnerable Plaque Heats Up," IN VIVO, October 2002 Also see "Vulnerable Plaque Heats Up" - In Vivo, 1 October, 2002.), key to the company's technology portfolio is a package of spectral analysis software, licensed from the Cleveland Clinic Foundation and called the Virtual Histology platform, that uses a radio frequency (RF) back scatter signal from IVUS to create automatic boundaries and geometry of the vessel [See Deal]. This allows for plaque characterization through what Volcano calls pseudo-histology, further enabling real-time diagnosis of vulnerable plaque
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?